REGENXBIO Inc. (RGNX) director receives new RSU and stock option grants
Rhea-AI Filing Summary
REGENXBIO Inc. director Allan M. Fox reported new equity awards and updated indirect holdings. He received 9,807 shares of common stock as a time-based restricted stock unit grant, with all shares scheduled to vest on May 29, 2027, subject to continuous service.
He was also granted stock options for 46,600 shares at an exercise price of $7.01 per share, vesting on May 29, 2027 and expiring on May 29, 2036. Following these grants, he directly holds 28,861 common shares.
The filing also lists indirect holdings of common stock through entities including Quaker Gray LLC with 1,529,981 shares, HBF Gift Trust LLC with 315,000 shares, AMF Gift Trust LLC with 315,000 shares, and AMF Family Gift Trust LLC with 722,485 shares, with beneficial ownership of these indirect positions disclaimed except for his indirect pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options (Right to Buy) | 46,600 | $0.00 | -- |
| Grant/Award | Common Stock | 9,807 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 29, 2027 subject to the continuous service of the recipient to the Issuer. The reporting person disclaims beneficial ownership of such shares except to the extent of his indirect pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose The option will vest on May 29, 2027 subject to the continuous service of the optionee to the Issuer.